Moo Ee Von, van Senten Jeffrey R, Bräuner-Osborne Hans, Møller Thor C
Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark
Mol Pharmacol. 2021 Apr;99(4):242-255. doi: 10.1124/molpharm.120.000192. Epub 2021 Jan 20.
Agonist-induced endocytosis is a key regulatory mechanism for controlling the responsiveness of the cell by changing the density of cell surface receptors. In addition to the role of endocytosis in signal termination, endocytosed G protein-coupled receptors (GPCRs) have been found to signal from intracellular compartments of the cell. Arrestins are generally believed to be the master regulators of GPCR endocytosis by binding to both phosphorylated receptors and adaptor protein 2 (AP-2) or clathrin, thus recruiting receptors to clathrin-coated pits to facilitate the internalization process. However, many other functions have been described for arrestins that do not relate to their role in terminating signaling. Additionally, there are now more than 30 examples of GPCRs that internalize independently of arrestins. Here we review the methods, pharmacological tools, and cellular backgrounds used to determine the role of arrestins in receptor internalization, highlighting their advantages and caveats. We also summarize key examples of arrestin-independent GPCR endocytosis in the literature and their suggested alternative endocytosis pathway (e.g., the caveolae-dependent and fast endophilin-mediated endocytosis pathways). Finally, we consider the possible function of arrestins recruited to GPCRs that are endocytosed independently of arrestins, including the catalytic arrestin activation paradigm. Technological improvements in recent years have advanced the field further, and, combined with the important implications of endocytosis on drug responses, this makes endocytosis an obvious parameter to include in molecular pharmacological characterization of ligand-GPCR interactions. SIGNIFICANCE STATEMENT: G protein-coupled receptor (GPCR) endocytosis is an important means to terminate receptor signaling, and arrestins play a central role in the widely accepted classical paradigm of GPCR endocytosis. In contrast to the canonical arrestin-mediated internalization, an increasing number of GPCRs are found to be endocytosed via alternate pathways, and the process appears more diverse than the previously defined "one pathway fits all."
激动剂诱导的内吞作用是通过改变细胞表面受体密度来控制细胞反应性的关键调节机制。除了内吞作用在信号终止中的作用外,人们还发现内吞的G蛋白偶联受体(GPCR)可在细胞内区室发出信号。一般认为,抑制蛋白是GPCR内吞作用的主要调节因子,它通过与磷酸化受体以及衔接蛋白2(AP-2)或网格蛋白结合,从而将受体招募到网格蛋白包被的小窝,以促进内化过程。然而,已经描述了抑制蛋白的许多其他功能,这些功能与其在终止信号传导中的作用无关。此外,现在有30多个GPCR的例子表明它们可以独立于抑制蛋白进行内化。在这里,我们综述了用于确定抑制蛋白在受体内化中作用的方法、药理学工具和细胞背景,强调了它们的优点和注意事项。我们还总结了文献中抑制蛋白非依赖性GPCR内吞作用的关键例子及其建议的替代内吞途径(例如,小窝依赖性和快速内吞蛋白介导的内吞途径)。最后,我们考虑了招募到独立于抑制蛋白进行内吞的GPCR的抑制蛋白的可能功能,包括催化性抑制蛋白激活模式。近年来技术的进步进一步推动了该领域的发展,再加上内吞作用对药物反应的重要影响,这使得内吞作用成为配体-GPCR相互作用分子药理学特征中一个明显需要纳入的参数。意义声明:G蛋白偶联受体(GPCR)内吞作用是终止受体信号传导的重要手段,抑制蛋白在广泛接受的GPCR内吞作用经典模式中起着核心作用。与经典的抑制蛋白介导的内化作用相反,越来越多的GPCR被发现通过替代途径进行内吞,而且这个过程似乎比之前定义的“一种途径适用于所有情况”更加多样化。